Count the members first
The count is what sets every position maximum. A 500 mg blend with fourteen names is a list, not a formula, and the arithmetic will show you that before the marketing does.
A blended panel is not blank. It has a shape, and the shape tells you more than most people extract from it. Here is how to read one.
A proprietary blend declares the combined weight of its ingredients and lists them in descending order of weight, with no individual amounts. From that you can derive a hard maximum for every ingredient, dividing the blend total by the ingredient's position in the list. You can prove a research dose impossible. You can never prove one adequate. That asymmetry is the whole practical consequence of a blended label.
The usual reaction to a proprietary blend is to give up on it. One number, a list of names, no amounts: there is nothing to read, so people read the marketing instead.
That is the wrong conclusion, and it is the reason this article exists. A blended panel carries real constraints, and a reader who knows what they are can extract a surprising amount from a label that looks like it says nothing.
The regulation is short. A blend must declare the total weight of all its dietary ingredients, and must list those ingredients in descending order of predominance by weight. Two obligations, and the second one is the useful one.
Descending order is a mathematical statement, not a stylistic choice. The first name weighs at least as much as the second. The second weighs at least as much as the third. That constraint propagates all the way down the list, and it is enough to build a ceiling for every position.
Worked on a 1,200 mg blend with eight members, which is the label this site happens to sell. The arithmetic is the same for any blend.
| Position in the list | Can weigh at most | Because |
|---|---|---|
| 1st | 1,200 mg | If it took the whole blend, the other seven would be zero, which is not permitted but sets the ceiling. |
| 2nd | 600 mg | The first weighs at least as much, so two of them cannot exceed the total together. |
| 3rd | 400 mg | Three ingredients each at least this large would already reach 1,200 mg. |
| 4th | 300 mg | Four at 300 is the total exactly, so 300 is the hard ceiling for fourth place. |
| 6th | 200 mg | Six at 200 is 1,200. Anything larger and the six above it break the total. |
| 8th | 150 mg | Eight at 150 is 1,200. The last position is always total ÷ count, and it is usually the most revealing figure on the label. |
Every one of those is an upper bound and none of them is an amount. The true figures sit at or below these lines, and the label will not say where.
Horse Honey Advanced Formula is a men’s performance capsule: eight ingredients sharing one 1,200 mg Test Boost Proprietary Blend, with no individual amounts published. We print the arithmetic the label leaves out.
Order NowRead the label firstHere is the single most useful move available to anybody reading a blended label, and it costs nothing but the arithmetic above.
Pick the ingredient that brought you to the product. Look up the dose the research actually used. Compare that dose against the position maximum you just calculated.
If the research dose is larger than the position maximum, you are finished. That dose is arithmetically impossible in this product, and no marketing copy, no blend name and no assurance from a seller changes it. You have proved something about a label that publishes no amounts.
If the research dose is smaller than the position maximum, you have learned considerably less. The dose is possible. Whether it is present is exactly what the label declines to say.
That asymmetry is worth sitting with, because it defines what a blended label can and cannot do for a buyer. You can disprove. You can never confirm. Every blend you ever read will be in one of those two states, and the second state is the common one.
Blend total divided by the ingredient's position in the list gives you its hard maximum. Compare that against the research dose. If the maximum loses, the question is settled; if it wins, you have learned only that the dose is not impossible.
The arithmetic above is neutral. The incentives are not, and this is the part that decides how much benefit of the doubt a blend deserves.
A company that has paid for a research-grade dose of an expensive ingredient has already spent the money. Printing the amount is free, and it is the strongest marketing claim the label could carry. There is no commercial reason to hide a number you are proud of.
The reverse case is where hiding does work. An ingredient present in a token quantity, so that its name can appear on the front of the bottle, is one whose amount would undermine the very claim it was bought to support. The blend is what allows the name to stay and the number to disappear.
So the expected direction is one-way. Hidden amounts protect small ones. That is an inference about incentives rather than a finding about any particular product, and plenty of well-dosed formulas sit inside blends for ordinary competitive reasons.
The point is that a reader outside the company cannot distinguish the two cases, and the cost of that uncertainty falls entirely on the person paying for the bottle.
None of these requires expertise and all of them take less than a minute.
The count is what sets every position maximum. A 500 mg blend with fourteen names is a list, not a formula, and the arithmetic will show you that before the marketing does.
It weighs the most, and it is very often the cheapest material in the blend. That single fact tells you where the manufacturing budget went.
A blend that also omits standardisation percentages is opaque twice over, because even a published milligram figure would not be comparable to a trial.
A company confident in its doses can send the breakdown in an email in five minutes without changing a thing on its label. The reply, or the silence, is information.
Horse Honey declares a Test Boost Proprietary Blend of 1,200 mg containing eight ingredients, with no individual amounts and no standardisation percentages. Its position maxima are exactly the ones in the table above. The one ingredient here with a placebo-controlled trial, tongkat ali, is second in the list, so its ceiling is 600 mg and the trial dose of 200 mg is not impossible. Whether it is present is what the panel does not say.
Plenty of well-dosed formulas sit inside proprietary blends for ordinary competitive reasons, and the regulation permitting them exists to protect real commercial interests. The criticism here is of what the choice costs a buyer, not of its legality, and it applies equally to every label in the category that makes the same choice.
Take a hypothetical product: a 750 mg Men's Vitality Blend with six ingredients, and the reason you picked it up is that tongkat ali is on the front.
Step one, find the position. Tongkat ali is listed fourth of six.
Step two, the position maximum. 750 divided by 4 is 187.5 mg. That is the absolute most it can be, and it assumes the three ingredients above it are each exactly the same weight, which would be an unusual formula.
Step three, the comparison. The placebo-controlled trial on tongkat ali used 200 mg a day of standardised aqueous root extract for twelve weeks. Your ceiling is 187.5 mg.
You are finished, and you never learned a single actual amount. The trial dose is arithmetically impossible in that product, the front of the bottle cannot change it, and the whole exercise took under a minute.
Run the same three steps on any blend you are considering. Most of the time the ceiling will clear the research dose and you will have learned only that it is possible, which is the honest state of most blended labels. Occasionally it will not, and those are the minutes best spent.
Stated plainly, because a technique oversold is worse than no technique.
Every output is an upper bound. Passing the ceiling test means possible, never present, and treating one as the other is the mistake this whole article is built to prevent.
A 200 mg extract standardised to 2% is not the same as one standardised to 10%. Where a label prints no standardisation, even a confirmed milligram figure would not be comparable to a trial.
Dose is one input. Absorption, form, your own baseline and whether the research applies to somebody like you are all separate questions, and arithmetic does not touch any of them.